 Axonics Modulation Technologies Inc NASDAQ: AXNX has acquired UK-based Contura and its lead product Bulkamid, a urethral bulking agent used to treat female stress urinary incontinence. The transaction includes a total consideration of 200 million in cash and stock, along with a potential future milestone of 35 million. 